Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lakhani

Showing results (201-210 of 311) with videos related to

Pageof 32
Sort By:
Oncogene|May 6, 2003
cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cellsAlan Mackay, Chris Jones, Tim Dexter, et al.
Oncotarget|April 26, 2014
Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancerFares Al-Ejeh, Mariska Miranda, Wei Shi, et al.
British Journal of Cancer|May 31, 2014
COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatmentD Generali, F M Buffa, S Deb, et al.
Oncogenesis|April 23, 2014
Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancerF Al-Ejeh, P T Simpson, J M Sanus, et al.
NPJ Breast Cancer|August 21, 2020
Using whole-genome sequencing data to derive the homologous recombination deficiency scoresXavier M de Luca, Felicity Newell, Stephen H Kazakoff, et al.
The Journal of Laryngology and Otology|March 24, 2017
Can trainees design and deliver a national audit of epistaxis management? A pilot of a secure web-based audit tool and research trainee collaborativesN Mehta, R J Williams, M E Smith, et al.
Molecular Cancer Therapeutics|July 19, 2012
Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancerAmelia A Peters, Peter T Simpson, Johnathon J Bassett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2025
Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the BreastGiuseppe Floris, Lounes Djerroudi, Gitte Zels, et al.
Rhinology|January 8, 2018
CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitisC Hopkins, R Hettige, A Soni-Jaiswal, et al.
Oncotarget|February 11, 2015
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell linesMajid Momeny, Jodi M Saunus, Flavia Marturana, et al.
Pageof 32

Showing results (201-210 of 311) with videos related to

Sort By:
Pageof 32
Oncogene|May 6, 2003
cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cellsAlan Mackay, Chris Jones, Tim Dexter, et al.
Oncotarget|April 26, 2014
Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancerFares Al-Ejeh, Mariska Miranda, Wei Shi, et al.
British Journal of Cancer|May 31, 2014
COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatmentD Generali, F M Buffa, S Deb, et al.
Oncogenesis|April 23, 2014
Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancerF Al-Ejeh, P T Simpson, J M Sanus, et al.
NPJ Breast Cancer|August 21, 2020
Using whole-genome sequencing data to derive the homologous recombination deficiency scoresXavier M de Luca, Felicity Newell, Stephen H Kazakoff, et al.
The Journal of Laryngology and Otology|March 24, 2017
Can trainees design and deliver a national audit of epistaxis management? A pilot of a secure web-based audit tool and research trainee collaborativesN Mehta, R J Williams, M E Smith, et al.
Molecular Cancer Therapeutics|July 19, 2012
Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancerAmelia A Peters, Peter T Simpson, Johnathon J Bassett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2025
Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the BreastGiuseppe Floris, Lounes Djerroudi, Gitte Zels, et al.
Rhinology|January 8, 2018
CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitisC Hopkins, R Hettige, A Soni-Jaiswal, et al.
Oncotarget|February 11, 2015
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell linesMajid Momeny, Jodi M Saunus, Flavia Marturana, et al.
Pageof 32